收藏切换
Research progress on the treatment of human epidermal growth factor receptor 2 positive breast cancer with traditional Chinese medicine combined with targeted drugs
收藏切换
Qingxiu SUN1, Fenghua PU2, *
World Clinical Drug | 2026, 47(7) : 818 - 824
Less
收藏切换
World Clinical Drug | 2026, 47(7): 818-824
• Review •
Research progress on the treatment of human epidermal growth factor receptor 2 positive breast cancer with traditional Chinese medicine combined with targeted drugs
Full
Qingxiu SUN1, Fenghua PU2, *
Affiliations
  • 1.Department of Pharmacy, Affiliated Hospital of North Sichuan Medical College, Nanchong 637000, Sichuan Province, China
  • 2.Department of Pharmacy, Southern County People's Hospital, Nanchong 637300, Sichuan Province, China
Published: 2026-07-10 doi: 10.13683/j.wph.2026.07.017
Outline
收藏切换

Human epidermal growth factor receptor(HER)2 positive breast cancer is a specific type of breast cancer that typically has a higher invasiveness and poorer prognosis. Targeted drugs such as trastuzumab and pertuzumab can specifically bind to HER2 receptors, inhibit the growth and spread of cancer cells, and prolong the survival of patients.traditional Chinese medicine(TCM), as a precious treasure of the nation, having accumulated rich experience in the treatment of breast cancer. It could enhance clinical treatment outcomes, reduce adverse reactions, improve patients'immune function, serve as an important complementary approach to breast cancer treatment. The combination of targeted drugs with TCM has achieved good results in the treatment of HER2 positive breast cancer. Based on the current situation of traditional Chinese medicine combined with targeted drugs in the treatment of HER2 positive breast cancer, this paper analyzed and summarized existing studies to provide a reference for comprehensive clinical treatment of breast cancer..

breast cancer  /  traditional Chinese medicine  /  targeted therapy  /  reverse drug resistance  /  enhance therapeutic efficacy
孙清秀, 蒲凤华. 中医药联合靶向药物治疗人表皮生长因子受体2阳性乳腺癌研究进展. 世界临床药物, 2026 , 47 (7) : 818 -824 . DOI: 10.13683/j.wph.2026.07.017
Qingxiu SUN, Fenghua PU. Research progress on the treatment of human epidermal growth factor receptor 2 positive breast cancer with traditional Chinese medicine combined with targeted drugs[J]. World Clinical Drug, 2026 , 47 (7) : 818 -824 . DOI: 10.13683/j.wph.2026.07.017
Year 2026 volume 47 Issue 7
55
10
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2026.07.017
  • Receive Date:2026-01-21
  • Online Date:2026-11-05
  • Published:2026-07-10
Article Data
Affiliations
History
  • Received:2026-01-21
Affiliations
    1.Department of Pharmacy, Affiliated Hospital of North Sichuan Medical College, Nanchong 637000, Sichuan Province, China
    2.Department of Pharmacy, Southern County People's Hospital, Nanchong 637300, Sichuan Province, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2026.07.017
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT